MedPath

Akron Pharma Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

12

FDA:12

Drug Approvals

Clotrimazole Topical Solution USP, 1%

Approval Date
Mar 26, 2024
FDA

Sodium Sulfacetamide 10% and Sulfur 5% Cleanser

Approval Date
Jan 18, 2024
FDA

Sodium Sulfacetamide 8% and Sulfur 4%

Approval Date
Mar 26, 2023
FDA

Sodium Sulfacetamide 10% and Sulfur 2% Cleanser

Approval Date
Mar 18, 2023
FDA

SODIUM SULFACETAMIDE

Approval Date
Mar 18, 2023
FDA

Sodium Sulfacetamide 9.8% and Sulfur 4.8% Cleanser

Approval Date
Mar 12, 2023
FDA

Sodium Sulfacetamide 9% - Sulfur 4.5% Wash

Approval Date
Mar 12, 2023
FDA

SODIUM SULFACETAMIDE

Approval Date
Mar 12, 2023
FDA

Sodium Sulfacetamide 9% - Sulfur 4%

Approval Date
Mar 12, 2023
FDA

Urea Cream 40%

Approval Date
Mar 11, 2023
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.